Winnergy Medical Public : Notification of the Resolution of the Annual General Meeting of Shareholders for the Year 2022
April 22, 2022 at 11:39 am IST
Share
Date/Time
22 Apr 2022 12:43:32
Headline
Notification of the Resolution of the Annual General Meeting of Shareholders for the Year 2022
Symbol
WINMED
Source
WINMED
Full Detailed News
Shareholders meeting's resolution
Subject : Shareholders meeting's resolution
Shareholder's meeting date : 22-Apr-2022
Meeting's resolution : Accordingly approved with board's
resolution
______________________________________________________________________
This announcement was prepared and disseminated by listed company or issuer
through the electronic system which is provided for the purpose of dissemination
of the information and related documents of listed company or issuer to the
Stock Exchange of Thailand only. The Stock Exchange of Thailand has no
responsibility for the correctness and completeness of any statements, figures,
reports or opinions contained in this announcement, and has no liability for any
losses and damages in any cases. In case you have any inquiries or
clarification regarding this announcement, please directly contact listed
company or issuer who made this announcement.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Winnergy Medical pcl published this content on 22 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 April 2022 06:07:09 UTC.
Winnergy Medical Public Company Limited is a Thailand-based company, which is engaged in the distribution of medical and diagnostics equipment. The Company imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The Company operates through two segments: Medical products and Other products. The Company's businesses include Trading business and Laboratory services. Its Trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The Company imports cytology and molecular microbiology products from Hologic Co., Ltd. from the United States. The Company imports products related to blood donation from Haemonetics Company of the United States. It distributes blood diagnostics products from Grifols, Spain. The Company also distributes clinical products, including reagents, such as Clinical cell separation, In vitro diagnostic (IVD) and Analyte specific reagents (ASR).